In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
The addition of ONIVYDE (irinotecan liposome injection) to fluorouracil and leucovorin significantly improves median overall survival and progression-free survival in patients with metastatic pancreatic cancer following gemcitabine-based therapy without compromising quality of life at 12 weeks when compared with fluorouracil and leucovorin alone